ns 1619 has been researched along with Cancer of Endometrium in 1 studies
NS 1619: structure given in first source
NS 1619 : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It is an opener/activator of the large-conductance calcium-activated potassium channel (Bkca).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, N | 1 |
| Liu, L | 1 |
| Li, G | 1 |
| Xia, M | 1 |
| Du, C | 1 |
| Zheng, Z | 1 |
1 other study available for ns 1619 and Cancer of Endometrium
| Article | Year |
|---|---|
The role of BKCa in endometrial cancer HEC-1-B cell proliferation and migration.
Topics: Benzimidazoles; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endometrial Neoplasms; Female; | 2018 |